Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium channel blockers and stroke.

Domenico Inzitari1, Anna Poggesi

  • 1Department of Neurological and Psychiatric Sciences, University of Florence, Florence, Italy. inzitari@neuro.unifi.it

Aging Clinical and Experimental Research
|April 28, 2006
PubMed
Summary

Calcium Channel Blockers (CCBs) effectively prevent strokes in hypertensive patients, showing benefits comparable or superior to other antihypertensives. They also offer neuroprotective effects and potential applications in managing vascular dementia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and clinical predictors of cognitive decline in anticoagulated patients with atrial fibrillation: the Strat-AF Study.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Atrial Fibrillation, Cerebral Small Vessel Disease and Gender Medicine: Focus on Biomarkers and Neuroimaging.

Journal of clinical medicine·2026
Same author

Stent placement as rescue treatment in acute basilar artery occlusion.

Journal of neurology·2026
Same author

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score.

Annals of clinical and translational neurology·2026
Same author

Defining the prognostic performance of multiphase CT-angiography in ischemic stroke patients.

European journal of radiology·2026
Same author

Characterization of "Perfusion Scotoma" in Acute Ischemic Stroke Following Endovascular Treatment.

AJNR. American journal of neuroradiology·2026

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Pharmacology

Background:

  • Hypertension is a primary risk factor for all stroke types, including atherothrombotic, lacunar, cardioembolic, and intraparenchymal hemorrhage.
  • Stroke pathophysiology is complex and variable, influencing the differential effects of preventive medications.
  • Acute stroke management requires careful blood pressure control, as rapid reduction can be detrimental.

Purpose of the Study:

  • To evaluate the efficacy of Calcium Channel Blockers (CCBs) in stroke prevention and management.
  • To explore the neuroprotective roles and potential applications of CCBs in cerebrovascular diseases and dementia.
  • To compare the effectiveness of CCBs against other antihypertensive agents in stroke prevention.

Main Methods:

Related Experiment Videos

  • Review of existing literature on CCB use in hypertension, stroke, and cerebrovascular conditions.
  • Analysis of CCB mechanisms of action, including antihypertensive, anti-atherosclerotic, and neuroprotective effects.
  • Examination of clinical data regarding CCB efficacy in preventing various stroke subtypes and managing post-stroke complications.

    • Main Results:

    • CCBs are effective in preventing stroke in hypertensive individuals, with outcomes similar to or better than other antihypertensives.
    • Specific CCBs, like nicardipine, are useful in acute stroke settings, and nimodipine is recommended for cerebral vasospasm post-subarachnoid hemorrhage.
    • CCBs demonstrate potential benefits in vascular dementia and reducing recurrent stroke risk due to their vascular and neuroprotective properties.

    Conclusions:

    • CCBs are a valuable therapeutic class for primary and secondary stroke prevention in hypertensive patients.
    • Their multifaceted actions, including anti-atherosclerotic and neuroprotective effects, extend their utility to managing cerebrovascular disorders and dementia.
    • CCBs offer a favorable risk-benefit profile in stroke prevention, particularly for specific stroke subtypes and post-hemorrhage complications.